The company focuses on the research and development, production and academic promotion of prescription drugs, focusing on cancer, cardiovascular and metabolic diseases, respiratory system and other fields, and its products cover more than 0/00 countries and regions around the world. [ 1]
On April 26th, 20021,the European Commission indicated that it had initiated legal proceedings against AstraZeneca for failing to comply with the vaccine supply contract in COVID-19 and having no reliable plan to ensure the delivery of the vaccine.
Since 1993 entered China, AstraZeneca has adhered to the supremacy of science and focused on innovation, so as to meet the growing medical demand in China and realize the grand vision of "pioneering and innovating, benefiting patients and becoming a reliable medical partner in China". Headquartered in China, AstraZeneca has more than 10000 employees in China, and its sales in China in 20 17 reached US$ 2.96 billion. The company invested more than 750 million US dollars in China, [2] invested in establishing production bases in Wuxi and Taizhou respectively, and established China Logistics Center in Wuxi. In China, AstraZeneca's business focuses on the treatment areas that China patients need most, including cardiovascular diseases, metabolic diseases, tumors, respiration, digestion and anesthesia. Get a leading position in the field of research and development [5]
AstraZeneca is an innovation-driven global biopharmaceutical company, focusing on the research, development, production and sales of prescription drugs, which has brought far-reaching changes to the medical industry. R&D and patients are the top priority of our work, and we will concentrate our strength and resources on the treatment field that can really make far-reaching changes. Committed to "constantly exploring the frontiers of science and developing life-changing drugs". Business strategy sets the road to success: pioneering and innovating, benefiting patients and becoming the most trusted medical partner in China. [5]
Accelerate business growth [6]
Drawing lessons from excellent global standards, deep understanding of local market and continuous investment, AstraZeneca China has been committed to providing more China patients with high-quality drugs in a faster way to meet the growing medical needs in China. [6] AstraZeneca's China headquarters is located in Zhangjiang High-tech Park, with several functional organizations, including R&D center and production bases in Wuxi and Taizhou. [7]
Become an ideal workplace